Mary Alma Welch Selected Research

Mary Alma Welch Research Topics

5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2024 - 01/2018
5	Neoplasms (Cancer) 12/2023 - 09/2003
4	Leukemia 12/2023 - 01/2021
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2023 - 05/2006
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 09/2003
3	Philadelphia Chromosome 01/2024 - 01/2022
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 01/2022
2	Acute Promyelocytic Leukemia 01/2022 - 01/2021
1	Hairy Cell Leukemia 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	COVID-19 01/2021
1	Acute Biphenotypic Leukemia (Leukemia, Mixed Cell) 11/2007
1	Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis) 05/2006
1	Thrombocytopenia (Thrombopenia) 06/2004
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 09/2003
1	Thrombocytosis (Thrombocythemia) 09/2003

4	Tyrosine Kinase InhibitorsIBA 01/2023 - 09/2003
3	blinatumomabIBA 01/2024 - 01/2022
3	Imatinib Mesylate (Gleevec)FDA Link 01/2012 - 09/2003
2	Indicators and Reagents (Reagents)IBA 12/2023 - 12/2023
2	venetoclaxIBA 01/2022 - 01/2021
2	Core Binding Factors (Core-Binding Factor)IBA 01/2022 - 01/2021
2	Dasatinib (BMS 354825)FDA Link 01/2022 - 01/2012
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 01/2021
1	AlbuminsIBA 12/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2023
1	BilirubinIBA 12/2023
1	CreatinineIBA 12/2023
1	Cladribine FDA LinkGeneric 01/2022
1	fludarabineIBA 01/2022
1	ponatinibIBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Arsenic Trioxide (Trisenox)FDA Link 01/2022
1	Gemtuzumab (Mylotarg)FDA Link 01/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022
1	Inotuzumab OzogamicinIBA 01/2018
1	nilotinib FDA Link 01/2012
1	nelarabine (506U78)FDA Link 11/2007
1	Everolimus FDA Link 05/2006
1	Sirolimus (Rapamycin)FDA Link 05/2006
1	oprelvekin (Neumega)FDA Link 06/2004
1	CytokinesIBA 06/2004
1	Interleukin-11 (Interleukin 11)IBA 06/2004
1	anagrelide (Agrylin)FDA LinkGeneric 09/2003
1	Oncogene Proteins (Oncogene Protein)IBA 09/2003

11	Therapeutics 01/2024 - 09/2003
9	Drug Therapy (Chemotherapy) 01/2024 - 06/2004
1	Stem Cell Transplantation 01/2024
1	Duration of Therapy 01/2022
1	Ambulatory Care (Outpatient Care) 01/2021